Luye Pharma Unit to Raise $150 Million via Boan-Linked Exchangeable Shares

MT Newswires Live11-21

Luye Pharma Group (HKG:2186) said a wholly owned unit has agreed to issue $150 million in exchangeable preference shares to an independent subscriber, according to a Friday Hong Kong bourse filing.

The shares, priced at $100 each, can be exchanged into Boan Biotech (HKG:6955) shares at an initial exchange price of HK$11.718. Upon full exchange, Boan Biotech would cease to be a subsidiary, the filing said.

The issuer will transfer 100.5 million Boan Biotech shares into a custodian account within 15 business days of completion to support future exchanges.

Dividends on the preference shares are fixed at 4.75% per annum, it added.

Luye said issuing the instruments provides immediate funding while enabling a gradual monetization of its Boan Biotech stake at a premium to market levels.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2585167841?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-21 09:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2585167841","market":"us","top_or_hot":-1,"title":"Luye Pharma Unit to Raise $150 Million via Boan-Linked Exchangeable Shares","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/LYPHF\">Luye Pharma</a> Group (HKG:2186) said a wholly owned unit has agreed to issue $150 million in exchangeable preference shares to an independent subscriber, according to a Friday Hong Kong bourse filing.</p><p>The shares, priced at $100 each, can be exchanged into Boan Biotech (HKG:6955) shares at an initial exchange price of HK$11.718. Upon full exchange, Boan Biotech would cease to be a subsidiary, the filing said.</p><p>The issuer will transfer 100.5 million Boan Biotech shares into a custodian account within 15 business days of completion to support future exchanges.</p><p>Dividends on the preference shares are fixed at 4.75% per annum, it added.</p><p>Luye said issuing the instruments provides immediate funding while enabling a gradual monetization of its Boan Biotech stake at a premium to market levels.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Luye Pharma Unit to Raise $150 Million via Boan-Linked Exchangeable Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLuye Pharma Unit to Raise $150 Million via Boan-Linked Exchangeable Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-11-21 09:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/LYPHF\">Luye Pharma</a> Group (HKG:2186) said a wholly owned unit has agreed to issue $150 million in exchangeable preference shares to an independent subscriber, according to a Friday Hong Kong bourse filing.</p><p>The shares, priced at $100 each, can be exchanged into Boan Biotech (HKG:6955) shares at an initial exchange price of HK$11.718. Upon full exchange, Boan Biotech would cease to be a subsidiary, the filing said.</p><p>The issuer will transfer 100.5 million Boan Biotech shares into a custodian account within 15 business days of completion to support future exchanges.</p><p>Dividends on the preference shares are fixed at 4.75% per annum, it added.</p><p>Luye said issuing the instruments provides immediate funding while enabling a gradual monetization of its Boan Biotech stake at a premium to market levels.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2585167841","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2585167841","pubTimestamp":1763689702,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Luye Pharma Group (HKG:2186) said a wholly owned unit has agreed to issue $150 million in exchangeable preference shares to an independent subscriber, according to a Friday Hong Kong bourse filing.The","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","02186":"绿叶制药","BK1583":"高瓴概念","BK1606":"中医药概念","BK1161":"生物科技","06955":"博安生物"},"translate_title":"绿叶制药子公司将通过博安相关可交换股筹集1.5亿美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02186":1,"06955":1},"content_text":"Luye Pharma Group (HKG:2186) said a wholly owned unit has agreed to issue $150 million in exchangeable preference shares to an independent subscriber, according to a Friday Hong Kong bourse filing.The shares, priced at $100 each, can be exchanged into Boan Biotech (HKG:6955) shares at an initial exchange price of HK$11.718. Upon full exchange, Boan Biotech would cease to be a subsidiary, the filing said.The issuer will transfer 100.5 million Boan Biotech shares into a custodian account within 15 business days of completion to support future exchanges.Dividends on the preference shares are fixed at 4.75% per annum, it added.Luye said issuing the instruments provides immediate funding while enabling a gradual monetization of its Boan Biotech stake at a premium to market levels.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2585167841","isCrawlerRequest":true}